These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1654317)

  • 21. Benzodiazepine receptor binding of benzodiazepine hypnotics: receptor and ligand specificity.
    Miller LG; Galpern WR; Byrnes JJ; Greenblatt DJ
    Pharmacol Biochem Behav; 1992 Oct; 43(2):413-6. PubMed ID: 1359574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of specific binding to the central benzodiazepine site to the brain concentrations of two novel benzodiazepine site ligands.
    Pike A; Cook SM; Watt AP; Scott-Stevens P; Rosahl TW; McKernan RM; Pym LJ; Guiblin A; Moyes C; Sohal B; Atack JR
    Biopharm Drug Dispos; 2007 Sep; 28(6):275-82. PubMed ID: 17570124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.
    Hilbert J; Pramanik B; Symchowicz S; Zampaglione N
    Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: a study of L-663,581 and its metabolites in rats.
    Lin JH; Chen IW; Lin TH
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1197-202. PubMed ID: 7996426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.
    Soldatos CR; Dikeos DG; Whitehead A
    Int Clin Psychopharmacol; 1999 Sep; 14(5):287-303. PubMed ID: 10529072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dependence on benzodiazepines. Clinical and biological aspects].
    Pelissolo A; Bisserbe JC
    Encephale; 1994; 20(2):147-57. PubMed ID: 7914165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appropriate use of benzodiazepines in insomnia: clinical update.
    Hishikawa Y
    J Clin Psychiatry; 1991 Jul; 52 Suppl():10-3. PubMed ID: 2071565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasma concentrations and clinical activity of benzodiazepines].
    Boyer P
    Encephale; 1983; 9(4 Suppl 2):59B-65B. PubMed ID: 6144531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM].
    Clarenbach P; Steinberg R; Weess HG; Berger M
    Nervenarzt; 1995 Oct; 66(10):723-9. PubMed ID: 7501087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Concept of half-life and benzodiazepine metabolism. Critical study].
    Cano JP; Coassolo P
    Encephale; 1983; 9(4 Suppl 2):75B-80B. PubMed ID: 6144533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of foods on the pharmacokinetics and clinical efficacy of quazepam.
    Kim Y; Morikawa M; Ohsawa H; Kou M; Ishida E; Igarashi J; Kajimoto T; Danno T; Nakata M; Yokoyama T; Tokuyama A; Nakamura Y; Kishimoto T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Oct; 23(5):205-10. PubMed ID: 14653226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative pharmacokinetics of 5 hypnotic benzodiazepines in healthy volunteers].
    Jochemsen R; Van Boxtel CJ; Breimer DD
    Nouv Presse Med; 1982 Oct; 11(40):2965-6. PubMed ID: 6128720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Variety and differences in activity of benzodiazepines (author's transl)].
    Gayral LF; Picard JF; Gardes JP
    Nouv Presse Med; 1982 May; 11(22):1668-73. PubMed ID: 6124932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonselective and selective benzodiazepine receptor agonists--where are we today?
    Mitler MM
    Sleep; 2000 Feb; 23 Suppl 1():S39-47. PubMed ID: 10755807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
    Araujo F; Ruano D; Vitorica J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sleep on quazepam kinetics.
    Hilbert JM; Chung M; Maier G; Gural R; Symchowicz S; Zampaglione N
    Clin Pharmacol Ther; 1984 Jul; 36(1):99-104. PubMed ID: 6734056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.